A sulfur-containing solvent that moves easily through skin. The strongest evidence supports two narrow uses: easing a chronic bladder condition (its only approved use) and protecting living cells during freezing. For muscle and joint pain and general anti-inflammatory benefit, the evidence is mixed and incompletely tested. Safety at low doses appears reasonable; industrial-grade product is the main avoidable danger. (Full Review)

Protocol

Bladder Instillation (Approved)

RIMSO-50, 50 mL retained ~15 min

Clinician-administered via catheter; every 1–2 weeks, then spaced for maintenance.

Topical (Off-Label)

50–90% solution to clean, dry skin

One to several times daily over the affected area; not standardized, no consensus dosing.

Grade & Titration

Pharmaceutical-grade ≥99.9% only

Start at lower concentration on a small area; divided applications limit irritation.

Time to effect

Bladder Instillation

Over a course of sessions

Benefits build across repeated treatments, not a single one.

Topical Pain Relief

Minutes to hours

When it occurs; effect is reported but not reliably demonstrated.

Garlic-Like Odor

Within minutes

Appears regardless of indication or timing; can persist a day or more.

Benefits

High: Symptom relief in interstitial cystitis / bladder pain syndrome; cryoprotection of living cells

Medium: Topical musculoskeletal pain and inflammation; healing of scleroderma digital ulcers

Low: Reduction of extravasation injury; antioxidant and anti-inflammatory "longevity" effects

Speculative: Neuroprotection after brain or spinal injury

Contraindications

Serious liver or kidney disease

Pregnancy and breastfeeding

Known DMSO hypersensitivity

Only industrial solvent-grade product available

Hepatic impairment (Child-Pugh Class B or C)

Advanced kidney disease (eGFR < 30 mL/min/1.73m²)

Key Interactions

Prescription topicals (corticosteroids, NSAIDs e.g. diclofenac)

OTC topicals (NSAID gels, salicylate rubs, capsaicin, antihistamine or hydrocortisone creams)

Supplements (herbal extracts, essential oils)

Sedative or vasodilatory agents, blood-pressure-lowering agents

Centrally acting agents

Risk & Side Effects

High: Garlic-like odor and taste; skin reactions at application sites; gastrointestinal symptoms

Medium: Absorption of contaminants from industrial-grade product; enhanced absorption and effect of co-applied substances

Low: Headache, dizziness, and sedation; bladder and instillation-related effects

Speculative: Lens (eye) changes; toxicity to developing or sensitive cells at high concentration

Monitoring

Marker	Target	Why
ALT / AST (liver enzymes)	ALT ~10–26 U/L; AST ~10–26 U/L	Confirm liver can clear DMSO metabolites
eGFR (estimated kidney filtration rate)	>90 mL/min/1.73m²	Kidneys excrete the MSM metabolite over days
Complete blood count (CBC)	Within normal limits, no new cytopenias	General safety screen with systemic exposure
Visual acuity / lens exam	No new lens opacity	Addresses the historical, unconfirmed lens-change concern

Cadence: For sustained or higher-dose use, recheck at baseline, then every 6–12 months, and sooner if new symptoms (e.g., persistent headache, visual changes) emerge.

Qualitative Assessment

Reduction in the targeted pain or bladder symptoms (the primary signal of benefit)
Tolerability of the garlic-like odor and absence of significant skin irritation
Energy levels and cognitive clarity unaffected (no persistent headache, dizziness, or sedation)
Subjective comfort and function (e.g., joint mobility, sleep undisturbed by pain)

DMSO for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment